Kevin Wyllie

Blue Note Therapeutics

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better. Blue Note is merging deep scientific and clinical expertise with digital and gaming innovation to transform care for seriously ill patients. Working closely with leading medical researchers and patient advocacy organizations, Blue Note is creating clinically-validated, FDA-approvable prescription-only digital devices to treat the burden of illness. Our team aims to make therapy available to any patient, at any time, on patients' own mobile devices. Patients and clinicians are our partners in developing programs that are highly effective and engaging so that it is easier for patients to stick with them.